IL69752A - Pharmaceutical compositions comprising cisplatinum and their preparation - Google Patents

Pharmaceutical compositions comprising cisplatinum and their preparation

Info

Publication number
IL69752A
IL69752A IL69752A IL6975283A IL69752A IL 69752 A IL69752 A IL 69752A IL 69752 A IL69752 A IL 69752A IL 6975283 A IL6975283 A IL 6975283A IL 69752 A IL69752 A IL 69752A
Authority
IL
Israel
Prior art keywords
cisplatinum
preparation
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL69752A
Other languages
English (en)
Other versions
IL69752A0 (en
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of IL69752A0 publication Critical patent/IL69752A0/xx
Publication of IL69752A publication Critical patent/IL69752A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
IL69752A 1982-09-23 1983-09-16 Pharmaceutical compositions comprising cisplatinum and their preparation IL69752A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23396/82A IT1153974B (it) 1982-09-23 1982-09-23 Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento

Publications (2)

Publication Number Publication Date
IL69752A0 IL69752A0 (en) 1983-12-30
IL69752A true IL69752A (en) 1986-07-31

Family

ID=11206716

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69752A IL69752A (en) 1982-09-23 1983-09-16 Pharmaceutical compositions comprising cisplatinum and their preparation

Country Status (20)

Country Link
US (1) US4670262A (da)
JP (1) JPS5978117A (da)
AT (1) AT382077B (da)
AU (1) AU559499B2 (da)
BE (1) BE897761A (da)
CA (1) CA1211372A (da)
CH (1) CH655852A5 (da)
DE (1) DE3333024A1 (da)
DK (1) DK157168C (da)
FI (1) FI78236C (da)
FR (1) FR2533439B1 (da)
GB (1) GB2127291B (da)
GR (1) GR79055B (da)
IE (1) IE56173B1 (da)
IL (1) IL69752A (da)
IT (1) IT1153974B (da)
NL (1) NL8303211A (da)
SE (1) SE464061B (da)
SU (1) SU1424722A3 (da)
ZA (1) ZA836904B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
IL76889A0 (en) * 1984-11-02 1986-02-28 Johnson Matthey Plc Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
JP2524217B2 (ja) * 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
CA2122342A1 (en) * 1992-09-04 1994-03-17 Hironori Kawabata Pharmaceutical composition
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
ATE363910T1 (de) * 1999-11-15 2007-06-15 Pharma Mar Sa Behandlung von krebserkrankungen durch aplidin
UA76718C2 (uk) * 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
BR0114604A (pt) * 2000-10-12 2003-10-14 Pharma Mar Sa Tratamento de c‰nceres
AU2002243646B2 (en) 2001-01-25 2006-06-22 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Formulation of boronic acid compounds
WO2003026642A1 (fr) * 2001-09-21 2003-04-03 Sumitomo Pharmaceuticals Co., Ltd. Preparation pharmaceutique lyophilisee
PT1435991E (pt) * 2001-10-19 2009-01-16 Pharma Mar Sa Utilização de aplidina para o tratamento de cancro pancreático
KR20060002778A (ko) * 2003-03-12 2006-01-09 파르마 마르, 에스.에이. 개선된 항종양 치료
AU2004218883B2 (en) * 2003-03-12 2009-10-01 Dana-Farber Cancer Institute, Inc. Aplidine for multiple myeloma treatment
DE50305909D1 (de) * 2003-10-13 2007-01-18 Salama Zoser B Pharmazeutische Zusammensetzung umfassend Oxoplatin und dessen Salze
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
ES2575518T3 (es) * 2006-02-28 2016-06-29 Pharma Mar S.A. Tratamiento mejorado de mieloma múltiple
AU2008313627A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
CN101965191A (zh) * 2008-03-07 2011-02-02 法马马有限公司 改善的抗癌治疗
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
CA2735899A1 (en) * 2008-09-25 2010-04-01 Cephalon, Inc. Liquid formulations of bendamustine
CN107773538B (zh) * 2016-08-27 2022-09-13 鲁南制药集团股份有限公司 稳定的甲啶铂无菌冻干粉末及其制备工艺
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432563A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum- co-ordination compounds
GB1432562A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
US4053587A (en) * 1973-04-13 1977-10-11 Research Corporation Method of treating viral infections
US4255417A (en) * 1976-08-04 1981-03-10 Johnson Matthey, Inc. Platinum compounds for the irradication of skin blemishes
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform
US4273755A (en) * 1979-08-16 1981-06-16 Mpd Technology Corporation Preparation of platinum complexes
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
US4451447A (en) * 1980-03-31 1984-05-29 Bristol-Myers Company Pharmaceutical formulations
CA1162479A (en) * 1980-03-31 1984-02-21 Murray A. Kaplan Pharmaceutical formulations containing cisplatin

Also Published As

Publication number Publication date
SU1424722A3 (ru) 1988-09-15
US4670262A (en) 1987-06-02
IT8223396A0 (it) 1982-09-23
NL8303211A (nl) 1984-04-16
GB2127291B (en) 1986-01-15
IT1153974B (it) 1987-01-21
FR2533439B1 (fr) 1986-08-14
AT382077B (de) 1987-01-12
FI833300A0 (fi) 1983-09-15
BE897761A (fr) 1984-01-02
FI78236B (fi) 1989-03-31
DK424383D0 (da) 1983-09-16
AU559499B2 (en) 1987-03-12
ZA836904B (en) 1984-10-31
GB2127291A (en) 1984-04-11
IL69752A0 (en) 1983-12-30
FR2533439A1 (fr) 1984-03-30
SE8304920D0 (sv) 1983-09-13
ATA326283A (de) 1986-06-15
GB8324380D0 (en) 1983-10-12
FI78236C (fi) 1989-07-10
SE8304920L (sv) 1984-03-24
IE56173B1 (en) 1991-05-08
SE464061B (sv) 1991-03-04
JPS5978117A (ja) 1984-05-04
DK157168B (da) 1989-11-20
DK157168C (da) 1990-04-09
CA1211372A (en) 1986-09-16
IE832172L (en) 1984-03-23
DE3333024A1 (de) 1984-03-29
DK424383A (da) 1984-03-24
AU1908983A (en) 1984-03-29
CH655852A5 (de) 1986-05-30
FI833300A (fi) 1984-03-24
GR79055B (da) 1984-10-02

Similar Documents

Publication Publication Date Title
IL69752A0 (en) Pharmaceutical compositions comprising cisplatinum and their preparation
IL67826A0 (en) Pyrazolooxazines,pyrazolothiazines and pyrazoloquinolines,their preparation and pharmaceutical compositions containing them
DE3468030D1 (en) 13-alpha-alkyl gonanes, their preparation and pharmaceutical compositions containing them
IL68421A0 (en) Pharmaceutical compositions containing oxicam and their preparation
IL68326A0 (en) Arene and hetero-arene carboxamides derivatives,their preparation and pharmaceutical compositions containing them
IL73951A0 (en) 2-phenyl-imidazoles,their preparation and pharmaceutical compositions containing them
IL71475A (en) N-aryl-alpha-amino-carboxamides,their preparation and pharmaceutical compositions containing them
IL68743A0 (en) N-formyl and n-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides,their preparation and pharmaceutical compositions containing them
IL68497A0 (en) Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing them
PH20168A (en) 7-carboxymethoxyphenylacetamino-3-cephem derivatives and their pharmaceutical compositions
IL68586A0 (en) 4-aryl-4-piperidinecarbinols,their preparation and pharmaceutical compositions containing them
IL68699A (en) 3-phenoxy-1-azetidine-carboxamides,their preparation and pharmaceutical compositions containing them
IL71419A0 (en) Phenylaminobenzenealkanols,their preparation and pharmaceutical compositions containing them
IL72307A0 (en) Pyridinyl-2-pyrimidinamines,their preparation and pharmaceutical compositions containing them
IL70158A (en) Tetrahydronaphthalene-carboxamides,their preparation and pharmaceutical compositions comprising them
IL71110A0 (en) Azolylmethylcycloalkanes,their preparation and pharmaceutical compositions containing them
IL70379A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
IL71661A0 (en) 4-phenyl-tetrahydro-furano-pyridines,their preparation and pharmaceutical compositions containing them
ZA832811B (en) Azabicyclobenzamides their preparation and their pharmaceutical compositions
GB2146023B (en) Aminocyclopentanes and their preparation and pharmaceutical formulation
IL68668A0 (en) Piperidinoquinazolines and pharmaceutical compositions containing them
ZA834539B (en) Pharmaceutical composition and its preparation and use
IL69817A (en) 7-anilinoisoquinoline-5,8-quinones,their preparation and pharmaceutical compositions comprising them
IL69010A (en) 15-alkoxyimino-14-oxoeburnamenines,their preparation and pharmaceutical compositions containing them
GB2138422B (en) Diphenylazomethines, their preparation and pharmaceutical compositions containing them